Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-12
2009-11-10
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07615551
ABSTRACT:
The present invention provides salt forms, and compositions thereof, useful as modulators of one or more GPCRs and which exhibit desirable characteristics for the same.
REFERENCES:
patent: 4438119 (1984-03-01), Allen et al.
patent: 4687772 (1987-08-01), Alderdice
patent: 4771053 (1988-09-01), Cott et al.
patent: 5162375 (1992-11-01), Nicholson et al.
patent: 5824680 (1998-10-01), Turner et al.
patent: 2005/0215526 (2005-09-01), Hulme et al.
patent: 2007/0059366 (2007-03-01), Ali et al.
patent: 2007/0060580 (2007-03-01), Deshmukh et al.
patent: 2007/0254876 (2007-11-01), Deshmukh et al.
patent: WO 93/04681 (1993-03-01), None
patent: WO 00/16777 (2000-03-01), None
patent: WO 00/43378 (2000-07-01), None
patent: WO 00/43378 (2000-07-01), None
patent: WO 01/14330 (2001-03-01), None
patent: WO 01/52855 (2001-07-01), None
patent: WO 02/066473 (2002-08-01), None
patent: WO 2005/061493 (2005-07-01), None
patent: WO 2007/033191 (2007-03-01), None
patent: WO 2007/033192 (2007-03-01), None
patent: WO 2007/033193 (2007-03-01), None
patent: WO 2007/033193 (2007-03-01), None
Lander et al. Nature 409:860 (2001).
Das and Khan. Prostaglandins Leukot Essent Fatty Acids 58:165 (1998).
Ungerstedt. Acta Physiol. Scand. 82: (suppl. 367) 69 (1971).
Sedvall et al. The Lancet, 346:743-749, (1995).
Hietala. The Lancet, 346:1130-1131 (1995).
Kemppainen et al. Eur J Neurosci., 18:149-154 (2003).
Kleven et al. European Journal of Pharmacology, 281:219-228 (1995).
Leone et al. Neuro Report, 9:2605-2608 (1998).
De Vry et al. European Journal of Pharmacology, 357:1-8 (1998).
Wolff et al. European Journal of Pharmacology, 340:217-220 (1997).
Alfieri et al. British Journal of Cancer, 72:1013-1015 (1995).
Wolff et al., Pharmacology Biochemistry and Behavior, 52:571-575 (1995).
Lucot. European Journal of Pharmacology, 253:53-60 (1997).
Rasmussen et al. Annual Reports in Medicinal Chemistry, 30:1-9 (1995).
Millan, Journal of Pharmacology and Experimental Therapeutics, 295:853-861 (2000).
Berge et al. “Pharmaceutical Salts,” Journal of Pharmaceutical Sciences, vol. 66, No. 1, Jan. 1977, pp. 1-19.
Hagger, et al. Biol. Psychiatry, 34:702 (1993).
Sharma et al. J. Clin. Psychopharmacol., 18:128 (1998).
Lee et al. J. Clin. Psychiatry, 55:82 (1994).
Fujii, et al. J. Neuropsychiatry Clin. Neurosci., 9:240 (1997).
Mason et al. Eur. J. Pharmacol., 221:397 (1992).
Newman-Tancredi et al. Neuropharmacology, 35:119, (1996).
Sumiyoshi et al. J. Clin. Pharmacol., 20:386 (2000).
Carli et al. Eur. J. Neurosci., 10:221 (1998).
Meneses et al. Neurobiol. Learn. Mem., 71:207 (1999).
Glennon et al. Neuroscience and Behavioral Reviews, 14:3547 (1990).
Masson et al. Pharm. Rev. 51:439 (1999).
Van Der Heyden and Bradford. Behav. Brain Res. 31:61 (1988).
Van Der Poel et al. Psychopharmacology, 97:147 (1989).
International Search Report for PCT/US2006/035519, Date of mailing:Dec. 7, 2006.
Office Action mailed Feb. 2, 2009, in co-pending U.S. Appl. No. 11/519,763.
Office Action mailed Apr. 9, 2008, in co-pending U.S. Appl. No. 11/519,756.
Office Action mailed Oct. 24, 2008, in co-pending U.S. Appl. No. 11/519,756.
Ali Kadum
Deshmukh Subodh S.
Diorio Christopher R.
Dulin Wendy
Ehrnsperger Eric C.
Finnegan Henderson Farabow Garrett & Dunner LLP
Habte Kahsay T
Solvay Pharmaceuticals B.V.
LandOfFree
Salicylate and gentisate salts of a piperazine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salicylate and gentisate salts of a piperazine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salicylate and gentisate salts of a piperazine compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4142147